ArticleFrontiers in pharmacology2026
LITAF suppresses breast cancer and paclitaxel resistance by ubiquitinating and degrading PCMT1 to inhibit COX-2-dependent arachidonic acid metabolism.
Na Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.